Carmichael Hill & Associates’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-69
Closed -$10K 849
2022
Q2
$10K Hold
69
0.01% 562
2022
Q1
$12K Sell
69
-31
-31% -$5.28K 0.01% 572
2021
Q4
$17K Buy
+100
New +$18.1K 0.01% 542

Other funds holding MSGS

Carmichael Hill & Associates's MSGS Position: Q3 2022 in Review

Carmichael Hill & Associates sold out of Madison Square Garden (MSGS) in Q3 2022, closing a stake of 69 shares — an estimated $10K sold.

Carmichael Hill & Associates first reported a position in MSGS in Q4 2021 and held it in 3 quarters. The position peaked at $17K in Q4 2021. 258 funds tracked by Wall St. Rank hold MSGS as of Q3 2022.

  • Carmichael Hill & Associates reported no remaining Madison Square Garden position as of Q3 2022 after selling out during the quarter.
  • Carmichael Hill & Associates sold 69 Madison Square Garden shares in Q3 2022, an estimated $10K.
  • Carmichael Hill & Associates first reported a position in Madison Square Garden in Q4 2021 and held it in 3 quarters.
  • Carmichael Hill & Associates's Madison Square Garden position peaked at $17K in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2022.

Based on Carmichael Hill & Associates's 13F filing for Q3 2022, filed 10 Nov 2022.